Alzheimer’s drug Leqembi promises to give patients more time, but they face a long road to treatment

by | Sep 8, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease. But the treatment promises to give patients such as …

FEATURED